RevMed

Beckman Coulter, Inc. C58961 Access SARS-CoV-2 IgG

Company Name
Beckman Coulter, Inc.
Catalog Number
C58961

Description

The Access SARS-CoV-2 IgG assay is a paramagnetic particle, chemiluminescent immunoassay intended for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum, serum separator tubes and plasma (lithium heparin, dipotassium EDTA, tripotassium EDTA, and sodium citrate). The Access SARS-CoV-2 IgG assay is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet requirements to perform moderate or high complexity tests.The Access SARS-CoV-2 IgG assay is only for use under the Food and Drug Administration's Emergency Use Authorization.
Have questions or need more information? Contact Us
RevMed is an independent marketplace for reselling medical devices and equipment. We are not affiliated with or endorsed by manufacturers, and all trademarks and brand names belong to their respective owners. Product images and descriptions are for reference only, and RevMed does not provide medical advice, training, or support.
Find Savings Automatically!
Your trusted browsing companion

Additional Details

Device Identifier
15099590738648
Is RX
Yes
Is Over the Counter
No
Requires Sterilization
No
Is Sterile
No
Is Single Use
No

Barcode Mapping

Unit of MeasurementEachesGTIN
Each115099590738648